SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (10032)9/30/2015 8:39:03 PM
From: scaram(o)uche  Respond to of 12215
 
>> All of the bulls <<

Well, guess I am one. Should have said uber-bulls.

more "it's magic" re. '1202.....

pbs.twimg.com



To: scaram(o)uche who wrote (10032)10/1/2015 10:44:08 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 12215
 
for the tgtx uber-bulls...... idelalisib plus anti-CD20......

pbs.twimg.com



To: scaram(o)uche who wrote (10032)10/2/2015 1:39:35 AM
From: tuck  Read Replies (1) | Respond to of 12215
 
No, thanks. Had we noted the Bayer version before? Certainly the dual isoform inhibition efficacy stuff is something I've pointed to in the past on the INFI thread. Wonder what the AE profile for copanlisib is like. Will look later unless someone beats me to it. Busy, only got time for superficial looks right now.

As for CLDX, that was a call, but never actually did the trade. Had I, I'd be thinking of covering now, indeed.

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News